Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] N NERVOUS SYSTEM N05 PSYCHOLEPTICS N05C HYPNOTICS AND SEDATIVES N05CD Benzodiazepine derivatives N05CD14 Remimazolam D10194 Remimazolam besylate (USAN) <JP/US> Therapeutic category of drugs in Japan [BR:br08301] 1 Agents affecting nervous system and sensory organs 11 Agents affecting central nervous system 111 General anesthetics 1119 Others D10194 Remimazolam besylate (USAN); Remimazolam besilate (JAN) Drug groups [BR:br08330] Neuropsychiatric agent DG01567 GABA-A receptor agonist DG03105 Remimazolam D10194 Remimazolam besylate Target-based classification of drugs [BR:br08310] Ion channels Ligand-gated ion channels GABA (ionotropic) GABR D10194 Remimazolam besylate (USAN) <JP/US> New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D10194 New drug approvals in Japan [br08318.html] Drugs with new active ingredients D10194 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D10194 Drug groups [BR:br08330] Neuropsychiatric agent DG01567 GABA-A receptor agonist DG03105 Remimazolam